RxDoctor Payments DataLook up a doctor →

Steven Bixler

Adult Health · Westerville, OHNPI 1669782553

Payments from drug & device makers

$11,040in general payments, 2019–2025

Across 608 payments — averaging $18.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Xeris Pharmaceuticals, Inc.$1K
  • Novo Nordisk$1K
  • Amgen$954
  • Lilly USA, LLC$810
  • Dexcom, Inc.$575
  • Boehringer Ingelheim$373
  • plus $6K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Xeris Pharmaceuticals, Inc.70$1,318
Novo Nordisk85$1,046
Amgen(2 entities)54$954
Lilly USA, LLC49$810
Dexcom, Inc.27$575
Boehringer Ingelheim22$373
Insulet Corporation15$351
Novartis19$337
Abbott18$336
Bayer18$310
Corcept Therapeutics15$289
BETA Bionics, Inc.14$258
Neurocrine Biosciences, Inc.9$248
Cequr Corporation4$244
Sanofi-aventis U.S. LLC13$228
AbbVie13$223
AstraZeneca(2 entities)15$222
Antares Pharma, Inc.12$217
Almatica Pharma LLC8$213
Medtronic7$193
Esperion Therapeutics, Inc.4$178
Radius Health, Inc.10$177
Amneal Pharmaceuticals LLC7$141
Amarin Pharma, Inc.7$135
IBSA Pharma Inc.8$130
Recordati_rare_diseases_inc.7$123
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC8$121
Pfizer6$113
Mannkind Corporation5$88
Kyowa Kirin, Inc.4$80
Madrigal Pharmaceuticals2$77
Endo USA, Inc.3$68
Ultragenyx Pharmaceutical Inc.3$68
Sandoz2$55
Tandem Diabetes Care, Inc.3$53
EUSA Pharma (US) LLC3$50
Ascensia Diabetes Care US Inc.3$47
Rhythm Pharmaceuticals, Inc.2$44
Endo Pharmaceuticals Inc.3$42
Chiesi USA, Inc.2$42
Sequel Med Tech, LLC2$40
Zealand Pharma US, Inc.3$38
Amphastar Pharmaceuticals, Inc.2$38
Averitas Pharma Inc.2$33
Tolmar, Inc.2$29
Amryt Pharma Holdings Ltd2$29
Kowa Pharmaceuticals America, Inc.2$24
Soleno Therapeutics, Inc.1$24
OPKO Pharmaceuticals, LLC1$23
Renalytix AI, Inc.1$20
Ascendis Pharma Endocrinology Inc1$20
Lifescan, Inc.1$18
Acella Pharmaceuticals, LLC1$18
Avvisto Therapeutics, LLC1$16
RGH Enterprises LLC1$16
Ipsen Biopharmaceuticals, Inc1$16
Acerus Pharmaceuticals Corporation1$14
Merck1$13
Currax Pharmaceuticals LLC1$12
Alfasigma USA, Inc.1$12

How this compares

$11,040 in reported general payments places this provider in the 95th percentile of 1,184 adult health providers in Ohio.

See all adult health providers in Ohio

Medicare billing

Part B allowed, 2024
$57,141
Medicare patients
303
Services billed
1,402

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult health in Westerville

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →